HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal parenchymal malakoplakia--a case report and review of the literature.

Abstract
Malakoplakia is an inflammatory condition associated with persisting bacterial antigen in macrophages and characterized histologically by the Michaelis-Gutmann body, containing bacterial fragments. We review the pathogenesis of malakoplakia and report a novel form of treatment successfully used in an 8-week-old infant with bilateral renal malakoplakia. The patient presented with an acute Escherichia coli urinary tract infection and enlarged kidneys. Antibiotic regimes were ineffective, but once the diagnosis was made treatment was changed to an immunosuppressive regime of prednisolone and azathioprine, to which she responded promptly. Renal malakoplakia should be considered in any patient with a urinary tract infection unresponsive to antibiotics and enlarged kidneys. Although a large proportion of patients with malakoplakia have an underlying systemic disorder, which may account for their abnormal macrophage function, the rest demonstrate either an isolated macrophage defect or no detectable anomaly at all. It is in this latter group we suggest that an immunomodulating regime can be curative.
AuthorsM A Saleem, D V Milford, F Raafat, R H White
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 7 Issue 3 Pg. 256-8 (Jun 1993) ISSN: 0931-041X [Print] Germany
PMID8518093 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Prednisolone
  • Azathioprine
Topics
  • Azathioprine (therapeutic use)
  • Escherichia coli Infections (drug therapy)
  • Female
  • Humans
  • Hypertrophy
  • Infant
  • Malacoplakia (drug therapy, pathology)
  • Nephritis (drug therapy, pathology)
  • Prednisolone (therapeutic use)
  • Urinary Tract Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: